Aeltsje Brinksma1, Petrie F Roodbol2, Esther Sulkers3, Willem A Kamps4, Eveline S J M de Bont4, Annemieke M Boot5, Johannes G M Burgerhof6, Rienk Y J Tamminga4, Wim J E Tissing4. 1. University of Groningen, University Medical Center Groningen, Beatrix Children's Hospital, Department of Pediatric Oncology and Hematology, Groningen, The Netherlands; University of Groningen, University Medical Center Groningen, School of Nursing and Health, Groningen, The Netherlands. Electronic address: a.brinksma@umcg.nl. 2. University of Groningen, University Medical Center Groningen, School of Nursing and Health, Groningen, The Netherlands. 3. University of Groningen, University Medical Center Groningen, Beatrix Children's Hospital, Department of Pediatric Oncology and Hematology, Groningen, The Netherlands; University of Groningen, University Medical Center Groningen, School of Nursing and Health, Groningen, The Netherlands. 4. University of Groningen, University Medical Center Groningen, Beatrix Children's Hospital, Department of Pediatric Oncology and Hematology, Groningen, The Netherlands. 5. University of Groningen, University Medical Center Groningen, Beatrix Children's Hospital, Department of Pediatric Endocrinology, Groningen, The Netherlands. 6. University of Groningen, University Medical Center Groningen, Department of Epidemiology, Groningen, The Netherlands.
Abstract
BACKGROUND & AIMS: Under- and overnutrition are linked to adverse outcomes during and after childhood cancer treatment. Therefore, understanding the timing of weight loss and weight gain and their contributory factors is essential for improving outcomes. We aimed to determine in which period of treatment changes in nutritional status occurred and which factors contributed to these changes. METHODS: A prospective cohort study of 133 newly diagnosed cancer patients with hematological, solid, and brain malignancies was performed. Anthropometric data and related factors were assessed at 0, 3, 6 and 12 months after diagnosis. RESULTS: Despite initial weight loss at the beginning of treatment in patients with hematological and solid malignancies, body mass index (BMI) and fat mass (FM) increased within 3 months with 0.13 SDS (P < 0.001) and 0.05 SDS (P = 0.021) respectively. Increase continued during the following months and resulted in a doubling of the number of overnourished patients. Fat free mass (FFM), which was already low at diagnosis, remained low. During the entire study period about 17% of the patients were undernourished on the basis of low FFM. Tube feeding and diminished activity level were related to increases in BMI and %FM respectively. No relationship was found between energy intake or corticosteroids and increase in BMI or %FM. CONCLUSIONS: BMI and FM increased during and after the period of intensive treatment, while FFM remained low. Improvement of nutritional status might be accomplished by increasing physical activity from the early phase of treatment.
BACKGROUND & AIMS: Under- and overnutrition are linked to adverse outcomes during and after childhood cancer treatment. Therefore, understanding the timing of weight loss and weight gain and their contributory factors is essential for improving outcomes. We aimed to determine in which period of treatment changes in nutritional status occurred and which factors contributed to these changes. METHODS: A prospective cohort study of 133 newly diagnosed cancerpatients with hematological, solid, and brain malignancies was performed. Anthropometric data and related factors were assessed at 0, 3, 6 and 12 months after diagnosis. RESULTS: Despite initial weight loss at the beginning of treatment in patients with hematological and solid malignancies, body mass index (BMI) and fat mass (FM) increased within 3 months with 0.13 SDS (P < 0.001) and 0.05 SDS (P = 0.021) respectively. Increase continued during the following months and resulted in a doubling of the number of overnourished patients. Fat free mass (FFM), which was already low at diagnosis, remained low. During the entire study period about 17% of the patients were undernourished on the basis of low FFM. Tube feeding and diminished activity level were related to increases in BMI and %FM respectively. No relationship was found between energy intake or corticosteroids and increase in BMI or %FM. CONCLUSIONS: BMI and FM increased during and after the period of intensive treatment, while FFM remained low. Improvement of nutritional status might be accomplished by increasing physical activity from the early phase of treatment.
Authors: Daniel V Runco; Karen Wasilewski-Masker; Courtney E McCracken; Martha Wetzel; Claire M Mazewski; Briana C Patterson; Ann C Mertens Journal: Clin Nutr ESPEN Date: 2020-06-02
Authors: Brianna R Murphy; Margaret P Raber; Karla D Crawford; Leslie Grasse; Lisa Wartenberg; Jimin Wu; Seyedeh S Dibaj; Joya Chandra Journal: Child Obes Date: 2020-03-13 Impact factor: 2.992
Authors: Emma Jacobine Verwaaijen; Annelienke van Hulst; Marta Fiocco; Annelies Hartman; Martha Grootenhuis; Saskia Pluijm; Rob Pieters; Erica van den Akker; Marry M van den Heuvel-Eibrink Journal: JMIR Res Protoc Date: 2022-04-11
Authors: Aeltsje Brinksma; Robbert Sanderman; Petrie F Roodbol; Esther Sulkers; Johannes G M Burgerhof; Eveline S J M de Bont; Wim J E Tissing Journal: Support Care Cancer Date: 2015-03-10 Impact factor: 3.603
Authors: Charles R Bendelsmith; Amy M Linabery; Amanda J Nickel; Rachel M Laquere; Katherine M Ingram; Melissa B Hansen; Julie A Pape-Blabolil; Mary M Skrypek; Anne E Bendel Journal: Neurooncol Pract Date: 2020-02-07
Authors: Daniel V Runco; Karen Wasilewski-Masker; Claire M Mazewski; Briana C Patterson; Ann C Mertens Journal: J Pediatr Hematol Oncol Date: 2021-11-01 Impact factor: 1.170